Computational examination to reveal Kaempferol as the most potent active compound from Euphorbia hirta against breast cancer by targeting AKT1 and ERα

References

• Chhikara BS, Parang K. Global cancer statistics 2022: the trends projection analysis. Chem Biol Lett. 2023;10(1):451.
   Web of Science ®Google Scholar
• Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. Ca A Cancer J Clinicians. 2023;73(1):17–48. doi: 10.3322/caac.21763
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA A Cancer J Clin. 2019;69(6):438–451. doi: 10.3322/caac.21583
   PubMed Web of Science ®Google Scholar
• Ahmed K, Asaduzzaman S, Bashar MI, et al. Association Assessment among risk factors and breast cancer in a low-income country: Bangladesh. Asian Pac J Cancer Prev. 2015;16(17):7507–7512. doi: 10.7314/APJCP.2015.16.17.7507
   PubMedGoogle Scholar
• Paul MR, Pan T, Pant DK, et al. Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets. J Clin Investig. 2020. doi: 10.1172/JCI129941
   Web of Science ®Google Scholar
• Clusan L, Ferrière F, Flouriot G, et al. A basic review on estrogen receptor signaling pathways in breast cancer. Int J Mol Sci. 2023;24(7):6834. doi: 10.3390/ijms24076834
   PubMed Web of Science ®Google Scholar
• Paplomata E, O’Regan R. The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers. Ther Adv Med Oncol. 2014;6(4):154–166. doi: 10.1177/1758834014530023
   PubMed Web of Science ®Google Scholar
• Golestan S, Soltani BM, Jafarzadeh M, et al. LINC02381 suppresses cell proliferation and promotes apoptosis via attenuating IGF1R/PI3K/AKT signaling pathway in breast cancer. Funct Integr Genomics. 2023;23(1):40. doi: 10.1007/s10142-023-00965-w
   PubMed Web of Science ®Google Scholar
• Mukohara T. PI3K mutations in breast cancer: prognostic and therapeutic implications. Breast Cancer (Dove Med Press). 2015;111. doi: 10.2147/BCTT.S60696
   PubMedGoogle Scholar
• Wu W, Chen Y, Huang L, et al. Effects of AKT1 E17K mutation hotspots on the biological behavior of breast cancer cells. J Clin Exp Pathol. 2020;13(3):332–346.
   Google Scholar
• Roy SS, Vadlamudi RK. Role of estrogen receptor signaling in breast cancer metastasis. Int J Breast Cancer. 2012;2012:1–8. doi: 10.1155/2012/654698
   Google Scholar
• Holst F, Stahl PR, Ruiz C, et al. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat Genet. 2007;39(5):655–660. doi: 10.1038/ng2006
   PubMed Web of Science ®Google Scholar
• Kumar S, Malhotra R, Kumar D. Euphorbia hirta: its chemistry, traditional and medicinal uses, and pharmacological activities. Phcog Rev. 2010;4(7):58. doi: 10.4103/0973-7847.65327
   Google Scholar
• Sharma N, Samarakoon K, Gyawali R, et al. Evaluation of the antioxidant, anti-inflammatory, and anticancer activities of Euphorbia hirta ethanolic extract. Molecules. 2014;19(9):14567–14581. doi: 10.3390/molecules190914567
   PubMed Web of Science ®Google Scholar
• Tran N, Nguyen M, Le KP, et al. Screening of antibacterial activity, antioxidant activity, and anticancer activity of Euphorbia hirta Linn Extracts. Appl Sci. 2020;10(23):8408. doi: 10.3390/app10238408
   Google Scholar
• Kalaivani S, Jayanthi S, Revathi K, et al. Phytochemical profile of Euphorbia hirta plant extract and its in vitro anticancer activity against the liver cancer HepG2 cells. Vegetos. 2023. doi: 10.1007/s42535-023-00621-5
   Google Scholar
• Abu Bakar FI, Abu Bakar MF, Abdullah N, et al. Optimization of extraction conditions of phytochemical compounds and anti-gout activity of Euphorbia hirta L. (Ara Tanah) using response surface methodology and liquid chromatography-mass spectrometry (LC-MS) analysis. Evid Based Complement Alternat Med. 2020;2020:1–13. doi: 10.1155/2020/4501261
   Web of Science ®Google Scholar
• Mekam PN, Martini S, Nguefack J, et al. Phenolic compounds profile of water and ethanol extracts of Euphorbia hirta L. leaves showing antioxidant and antifungal properties. S Afr J Bot. 2019;127:319–332. doi: 10.1016/j.sajb.2019.11.001
   Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717. doi: 10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Banerjee P, Eckert AO, Schrey AK, et al. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46(W1):W257–W263. doi: 10.1093/nar/gky318
   PubMed Web of Science ®Google Scholar
• Lomize AL, Hage JM, Schnitzer K, et al. PerMM: a web tool and database for analysis of passive membrane permeability and translocation pathways of bioactive molecules. J Chem Inf Model. 2019;59(7):3094–3099. doi: 10.1021/acs.jcim.9b00225
   PubMed Web of Science ®Google Scholar
• Filimonov DA, Lagunin AA, Gloriozova TA, et al. Prediction of the biological activity spectra of organic compounds using the pass Online web resource. Chem Heterocycl Comp. 2014;50(3):444–457. doi: 10.1007/s10593-014-1496-1
   Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47(W1):W357–W364. doi: 10.1093/nar/gkz382
   PubMed Web of Science ®Google Scholar
• Davis AP, Grondin CJ, Johnson RJ, et al. Comparative toxicogenomics database (CTD): update 2021. Nucleic Acids Res. 2021;49(D1):D1138–D1143. doi: 10.1093/nar/gkaa891
   PubMed Web of Science ®Google Scholar
• Kuhn M, Szklarczyk D, Franceschini A, et al. STITCH 3: zooming in on protein-chemical interactions. Nucleic Acids Res. 2012;40(D1):D876–D880. doi: 10.1093/nar/gkr1011
   PubMed Web of Science ®Google Scholar
• Sherman BT, Hao M, Qiu J, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216–W221. doi: 10.1093/nar/gkac194
   PubMed Web of Science ®Google Scholar
• O’Boyle NM, Banck M, James CA, et al. Open babel: an open chemical toolbox. J Cheminform. 2011;3(1):33. doi: 10.1186/1758-2946-3-33
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2009;31(2):NA–NA. doi: 10.1002/jcc.21334
   Web of Science ®Google Scholar
• Weisner J, Landel I, Reintjes C, et al. Preclinical efficacy of Covalent-Allosteric AKT inhibitor Borussertib in combination with trametinib in KRAS -mutant pancreatic and colorectal cancer. Cancer Res. 2019;79(9):2367–2378. doi: 10.1158/0008-5472.CAN-18-2861
   PubMed Web of Science ®Google Scholar
• Shiau AK, Barstad D, Loria PM, et al. The structural Basis of estrogen receptor/Coactivator Recognition and the antagonism of this interaction by tamoxifen. Cell. 1998;95(7):927–937. doi: 10.1016/S0092-8674(00)81717-1
   PubMed Web of Science ®Google Scholar
• Krieger E, Vriend G. YASARA view—molecular graphics for all devices—from smartphones to workstations. Bioinformatics. 2014;30(20):2981–2982. doi: 10.1093/bioinformatics/btu426
   PubMed Web of Science ®Google Scholar
• Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Espert Opin Drug Discov. 2015;10(5):449–461. doi: 10.1517/17460441.2015.1032936
   PubMed Web of Science ®Google Scholar
• Chen AY, Chen YC. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem. 2013;138(4):2099–2107. doi: 10.1016/j.foodchem.2012.11.139
   PubMed Web of Science ®Google Scholar
• Ulrih NP, Maričić M, Ota A, et al. Kaempferol and quercetin interactions with model lipid membranes. Food Res Int. 2015;71:146–154. doi: 10.1016/j.foodres.2015.02.029
   Web of Science ®Google Scholar
• Milenković D, Dimitrić Marković JM, Dimić D, et al. Structural characterization of kaempferol: a spectroscopic and computational study. Maced J Chem Chem Eng. 2019;38(1):49. doi: 10.20450/mjcce.2019.1333
   Web of Science ®Google Scholar
• Hung TM, Dang NH, Kim JC, et al. Phenolic glycosides from Alangium salviifolium leaves with inhibitory activity on LPS-induced NO, PGE2, and TNF-α production. Bioorg Med Chem Lett. 2009;19(15):4389–4393. doi: 10.1016/j.bmcl.2009.05.070
   PubMed Web of Science ®Google Scholar
• Wang J, Fang X, Ge L, et al. Antitumor, antioxidant and anti-inflammatory activities of kaempferol and its corresponding glycosides and the enzymatic preparation of kaempferol. PLoS One. 2018;13(5):e0197563. doi: 10.1371/journal.pone.0197563
   PubMed Web of Science ®Google Scholar
• Imran M, Salehi B, Sharifi-Rad J, et al. Kaempferol: a key emphasis to its anticancer potential. Molecules. 2019;24(12):2277. doi: 10.3390/molecules24122277
   PubMed Web of Science ®Google Scholar
• Bickerton GR, Paolini GV, Besnard J, et al. Quantifying the chemical beauty of drugs. Nat Chem. 2012;4(2):90–98. doi: 10.1038/nchem.1243
   PubMed Web of Science ®Google Scholar
• Lomize AL, Pogozheva ID. Physics-based method for modeling passive membrane permeability and translocation pathways of bioactive molecules. J Chem Inf Model. 2019;59(7):3198–3213. doi: 10.1021/acs.jcim.9b00224
   PubMed Web of Science ®Google Scholar
• Pantsar T, Poso A. Binding affinity via docking: fact and fiction. Molecules. 2018;23(8):1899. doi: 10.3390/molecules23081899
   PubMed Web of Science ®Google Scholar
• Majewski M, Ruiz-Carmona S, Barril X. An investigation of structural stability in protein-ligand complexes reveals the balance between order and disorder. Commun Chem. 2019;2(1):110. doi: 10.1038/s42004-019-0205-5
   Google Scholar
• Martínez L, Kleinjung J. Automatic identification of Mobile and rigid substructures in Molecular dynamics Simulations and fractional structural fluctuation analysis. PLoS One. 2015;10(3):e0119264. doi: 10.1371/journal.pone.0119264
   PubMed Web of Science ®Google Scholar
• Pace CN, Fu H, Lee Fryar K, et al. Contribution of hydrogen bonds to protein stability: hydrogen bonds and protein stability. Protein Sci. 2014;23(5):652–661. doi: 10.1002/pro.2449
   PubMed Web of Science ®Google Scholar
• Kumar N, Sood D, Tomar R, et al. Antimicrobial peptide designing and optimization employing large-scale flexibility analysis of protein-peptide fragments. ACS Omega. 2019;4(25):21370–21380. doi: 10.1021/acsomega.9b03035
   PubMed Web of Science ®Google Scholar
• Wargasetia TL, Ratnawati H, Widodo N, et al. Bioinformatics study of sea cucumber peptides as antibreast cancer through inhibiting the activity of overexpressed protein (EGFR, PI3K, AKT1, and CDK4). Cancer Inform. 2021;20:1–11. doi: 10.1177/11769351211031864
   Web of Science ®Google Scholar
• Bhardwaj VK, Singh R, Sharma J, et al. Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. J Biomol Struct Dyn. 2021;39(10):3449–3458. doi: 10.1080/07391102.2020.1766572
   PubMed Web of Science ®Google Scholar
• Ajmani S, Agrawal A, Kulkarni SA. A comprehensive structure–activity analysis of protein kinase B-alpha (Akt1) inhibitors. J Mol Graph Model. 2010;28(7):683–694. doi: 10.1016/j.jmgm.2010.01.007
   PubMed Web of Science ®Google Scholar
• Lin K, Lin J, Wu W-I, et al. An ATP-Site on-off switch that restricts phosphatase accessibility of Akt. Sci Signal. 2012;5(223). doi: 10.1126/scisignal.2002618
   Web of Science ®Google Scholar
• Ciruelos Gil EM. Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer. Cancer Treat Rev. 2014;40(7):862–871. doi: 10.1016/j.ctrv.2014.03.004
   PubMed Web of Science ®Google Scholar
• Saura C, Roda D, Roselló S, et al. A first-in-human phase I study of the ATP-Competitive AKT inhibitor ipatasertib demonstrates robust and safe targeting of AKT in patients with solid tumors. Cancer Discov. 2017;7(1):102–113. doi: 10.1158/2159-8290.CD-16-0512
   PubMed Web of Science ®Google Scholar
• Kumar R, Zakharov MN, Khan SH, et al. The dynamic structure of the estrogen receptor. J Amino Acids. 2011;2011:1–7. doi: 10.4061/2011/812540
   Google Scholar
• Arnal J-F, Lenfant F, Metivier R, et al. Membrane and nuclear estrogen receptor alpha actions: from tissue specificity to medical implications. Physiol Rev. 2017;97(3):1045–1087. doi: 10.1152/physrev.00024.2016
   PubMed Web of Science ®Google Scholar
• Yaşar P, Ayaz G, User SD, et al. Molecular mechanism of estrogen-estrogen receptor signaling. Reprod Med Biol. 2017;16(1):4–20. doi: 10.1002/rmb2.12006
   PubMed Web of Science ®Google Scholar
• Feng Y, Spezia M, Huang S, et al. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018;5(2):77–106. doi: 10.1016/j.gendis.2018.05.001
   PubMed Web of Science ®Google Scholar
• Miyoshi Y, Murase K, Saito M, et al. Mechanisms of estrogen receptor-α upregulation in breast cancers. Med Mol Morphol. 2010;43(4):193–196. doi: 10.1007/s00795-010-0514-3
   PubMed Web of Science ®Google Scholar
• Xin L, Min J, Hu H, et al. Structure-guided identification of novel dual-targeting estrogen receptor α degraders with aromatase inhibitory activity for the treatment of endocrine-resistant breast cancer. Eur J Med Chem. 2023;253:115328. doi: 10.1016/j.ejmech.2023.115328
   PubMed Web of Science ®Google Scholar